Cargando…

XL888 limits vemurafenib-induced proliferative skin events by suppressing paradoxical MAPK activation

Detalles Bibliográficos
Autores principales:	Phadke, Manali, Gibney, Geoffrey T., Rich, Carolyn J., Fedorenko, Inna V., Chen, Y. Ann, Kudchadkar, Ragini R., Sondak, Vernon K., Weber, Jeffrey, Messina, Jane L., Smalley, Keiran S. M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4567904/ https://www.ncbi.nlm.nih.gov/pubmed/26039542 http://dx.doi.org/10.1038/jid.2015.205

Ejemplares similares

Inhibition of BRAF and BRAF+MEK drives a metastatic switch in melanoma
por: Smalley, Keiran SM, et al.
Publicado: (2015)

Beyond BRAF: where next for melanoma therapy?
por: Fedorenko, I V, et al.
Publicado: (2015)

LMD-03. Single cell analysis reveals how therapy remodels the tumor microenvironment in melanoma CNS metastases and uncovers a novel predictor of improved survival
por: Smalley, Inna, et al.
Publicado: (2021)

OTME-17. Single cell characterization of the immune microenvironment of melanoma brain and leptomeningeal metastases
por: Smalley, Inna, et al.
Publicado: (2021)

The complexity of microenvironment-mediated drug resistance
por: Fedorenko, Inna V., et al.
Publicado: (2015)

BRAF inhibition generates a host/tumor niche that mediates therapeutic escape
por: Fedorenko, Inna V., et al.
Publicado: (2015)

High-Content, High-Throughput Analysis of Cell Cycle Perturbations Induced by the HSP90 Inhibitor XL888
por: Lyman, Susan K., et al.
Publicado: (2011)

Fibronectin induction abrogates the BRAF inhibitor response of BRAF V600E/PTEN-null melanoma cells
por: Fedorenko, Inna V., et al.
Publicado: (2015)

Correction: High-Content, High-Throughput Analysis of Cell Cycle Perturbations Induced by the HSP90 Inhibitor XL888
por: Lyman, Susan K., et al.
Publicado: (2011)

Dabrafenib inhibits the growth of BRAF‐WT cancers through CDK16 and NEK9 inhibition
por: Phadke, Manali, et al.
Publicado: (2017)

Clinical results of combined vemurafenib and tumor-infiltrating lymphocyte therapy for metastatic melanoma
por: Sarnaik, Amod, et al.
Publicado: (2015)

Dynamic transcriptome analysis reveals signatures of paradoxical effect of vemurafenib on human dermal fibroblasts
por: Corrales, Eyleen, et al.
Publicado: (2021)

miR-888: Hit it when you see it!
por: Bader, Andreas G
Publicado: (2014)

Leveraging transcriptional dynamics to improve BRAF inhibitor responses in melanoma
por: Smalley, Inna, et al.
Publicado: (2019)

Evaluation of Concurrent Radiation, Temozolomide and ABT-888 Treatment Followed by Maintenance Therapy with Temozolomide and ABT-888 in a Genetically Engineered Glioblastoma Mouse Model
por: Lemasson, Benjamin, et al.
Publicado: (2016)

SinCHet: a MATLAB toolbox for single cell heterogeneity analysis in cancer
por: Li, Jiannong, et al.
Publicado: (2017)

888. Improving outcomes with revised preoperative universal decolonization protocol
por: Gnass, Silvia I
Publicado: (2020)

888. A Predictive Model for Subtherapeutic Vancomycin Troughs in Adults
por: Crisp, Sarah, et al.
Publicado: (2022)

Recovery of phospho-ERK activity allows melanoma cells to escape from BRAF inhibitor therapy
por: Paraiso, K H T, et al.
Publicado: (2010)

Vemurafenib improves muscle histopathology in a mouse model of LAMA2-related congenital muscular dystrophy
por: Oliveira-Santos, Ariany, et al.
Publicado: (2023)

Combined vemurafenib and fotemustine in patients with BRAF V600 melanoma progressing on vemurafenib
por: Queirolo, Paola, et al.
Publicado: (2016)

Preparation and Characterization of Metformin Hydrochloride — Compritol 888 ATO Solid Dispersion
por: Jagdale, SC, et al.
Publicado: (2011)

ABT-888 restores sensitivity in temozolomide resistant glioma cells and xenografts
por: Yuan, Alice L., et al.
Publicado: (2018)

Evaluation of ABT-888 in the amelioration of α-synuclein fibril-induced neurodegeneration
por: Hastings, Lyndsay, et al.
Publicado: (2022)

Gingival neoplasms: a multicenter collaborative study of 888 patients in Brazil
por: Santos-Leite, Éder Gerardo, et al.
Publicado: (2023)

Why do women with melanoma do better than men?
por: Smalley, Keiran SM
Publicado: (2018)

Melanoma Expressed-CD70 Is Regulated by RhoA and MAPK Pathways without Affecting Vemurafenib Treatment Activity
por: Pich, Christine, et al.
Publicado: (2016)

Scurvy in a patient on vemurafenib
por: Gerstenblith, Meg R., et al.
Publicado: (2014)

General view downstream from Compass - NA58 experiment in the 888 hall
por: André FROTON
Publicado: (2001)

The PARP inhibitor ABT-888 potentiates darbazine-induced cell death in carcinoids
por: Somnay, Yash, et al.
Publicado: (2016)

Effect of ABT-888 on the apoptosis, motility and invasiveness of BRAFi-resistant melanoma cells
por: Fratangelo, Federica, et al.
Publicado: (2018)

miR-888 functions as an oncogene and predicts poor prognosis in colorectal cancer
por: Gao, Su-Jun, et al.
Publicado: (2018)

Comparing Bleeding and Thrombotic Rates in Spine Surgery: An Analysis of 119 888 Patients
por: Pirkle, Sean, et al.
Publicado: (2019)

XL odas /
por: Horacio
Publicado: (1946)

MathXL
por: Bittinger, Marvin L
Publicado: (2006)

XL odas selectas = XL Odae Selectae
por: Horacio
Publicado: (1946)

Splice-acceptor site mutation in p53 gene of hu888 zebrafish line
por: Piasecka, Alicja, et al.
Publicado: (2014)

Complete genome sequence of human pathogen Kosakonia cowanii type strain 888-76(T)
por: Yang, Xue-Jing, et al.
Publicado: (2017)

888 Performance Characteristics and Associated Outcomes for an Automated Surveillance Tool for Blood Stream Infection
por: Ridgway, Jessica P., et al.
Publicado: (2014)

888. In Vitro Forgiveness of INSTI-Containing Regimens at Drug Concentrations Simulating Variable Adherence
por: Acosta, Rima K, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_fvs09v44s58nkjrmg233quldjm